EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-814 Cr | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr | ₹-189 Cr |
What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-814 Cr |
| Mar2024 | ₹-164 Cr |
| Mar2023 | ₹-145 Cr |
| Mar2022 | ₹-152 Cr |
| Mar2021 | ₹-189 Cr |
How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-814 Cr | Negative | |
| Mar2024 | ₹-164 Cr | Negative | |
| Mar2023 | ₹-145 Cr | Negative | |
| Mar2022 | ₹-152 Cr | Negative | |
| Mar2021 | ₹-189 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹28,626.8 Cr | -3.3% | 1.4% | 54.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -3.3% |
1.4% |
54.3% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses